SUBK 22.99 Suffolk Bancorp $SUBK Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 4:56 AM

SUBK 22.99 Suffolk Bancorp $SUBK Hit a 52 week high of 23.11 Currently at 22.99 +0.07 +0.31% With a day low of 22.65 and a total volume of 18,300.

SUBK Suffolk Bancorp Recent Headline News

Suffolk Bancorp Announces Sale of Wealth Management Business to Beacon Trust
GlobeNewswire - Mon Nov 03, 8:36AM CST
Suffolk Bancorp ("Suffolk"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank"

, today announced that the Bank has completed the sale of its Wealth Management business to Beacon Trust Company ("Beacon"

.
PFS: 18.16 (+0.03), SUBK: 22.99 (+0.07)

Suffolk Bancorp Declares Quarterly Dividend
GlobeNewswire - Wed Oct 29, 7:35AM CDT
Suffolk Bancorp (the "Company"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank"

, announced that its Board of Directors today declared a quarterly cash dividend of $0.06 per share on its common stock. The dividend will be payable on November 26, 2014 to shareholders of record as of November 12, 2014.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Reports Third Quarter 2014 Results
GlobeNewswire - Thu Oct 23, 7:00AM CDT
Third Quarter 2014 Highlights
SUBK: 22.99 (+0.07)

Suffolk Bancorp Selected for Sandler O'Neill Sm-All Stars Class of 2014, Top Performing Small-Cap Banks and Thrifts
GlobeNewswire - Thu Oct 02, 8:48AM CDT
Suffolk Bancorp (Nasdaq:SUBK), parent company of Suffolk County National Bank, announced that it has been named one of the Sandler O'Neill Sm-All Stars Class of 2014. Suffolk Bancorp was one of thirty-five publicly traded banks and thrifts selected among 443 depository institutions from across the country with market cap less than $2.5 billion. The Sm-All Stars designation was established to identify the top performing small-cap banks and thrifts in the U.S. Performance metrics of Sm-All Star institutions are exceptional, exceeding the industry metrics. Companies were selected based on various financial screening criteria, including growth, profitability, credit quality and capital strength.
SUBK: 22.99 (+0.07)

Sun National Bank Announces Hiring of Patricia Schaubeck as Executive Vice President and General Counsel
PR Newswire - Tue Sep 16, 3:30PM CDT
Sun Bancorp, Inc. (NASDAQ: SNBC) (the "Company"

and its primary subsidiary, Sun National Bank (the "Bank"

, announced the appointment of Patricia Schaubeck as Executive Vice President and General Counsel.
SNBC: 19.97 (-0.01), STB: 6.29 (+0.10), SUBK: 22.99 (+0.07)

Suffolk Bancorp Reinstates Quarterly Dividend
GlobeNewswire - Wed Jul 30, 7:45AM CDT
Suffolk Bancorp (the "Company"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank"

, announced that its Board of Directors today declared a quarterly cash dividend of $0.06 per share on its common stock. The dividend will be payable on August 27, 2014 to shareholders of record as of August 13, 2014. This cash dividend represents the first dividend the Company has paid since January 6, 2011. Based on the July 29, 2014 closing price of $20.89 per share, the annualized dividend yield on the Company's common stock would be 1.15%.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Reports Second Quarter 2014 Results
GlobeNewswire - Tue Jul 22, 7:00AM CDT
2Q 2014 Highlights
SUBK: 22.99 (+0.07)

Suffolk Bancorp Announces Opening of New Branch Office in Melville
GlobeNewswire - Mon Jun 30, 10:45AM CDT
Suffolk Bancorp (the "Company"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank," "SCNB"

, today announced that the Bank has opened a new Branch Office at 290 Broadhollow Road, Suite 100E, Melville, NY.
SUBK: 22.99 (+0.07)

Shares of SUBK Up 9.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Mar 28, 5:12PM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on February 28th, 2014 at $20.13. In approximately 4 weeks, Suffolk Bancorp has returned 9.74% as of today's recent price of $22.09.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Up 23.7% Since SmarTrend Uptrend Call (SUBK)
Comtex SmarTrend(R) - Tue Aug 27, 5:12PM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on January 18th, 2013 at $13.84. In approximately 7 months, Suffolk Bancorp has returned 23.67% as of today's recent price of $17.11.
SUBK: 22.99 (+0.07)

Uptrend Call Working As Suffolk Bancorp Stock Rises 27.7% (SUBK)
Comtex SmarTrend(R) - Tue Aug 20, 11:38AM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on January 18th, 2013 at $13.84. In approximately 7 months, Suffolk Bancorp has returned 27.72% as of today's recent price of $17.67.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Shares Up 32.6% Since SmarTrend's Buy Recommendation (SUBK)
Comtex SmarTrend(R) - Tue Aug 13, 9:52AM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on January 18th, 2013 at $13.84. In approximately 7 months, Suffolk Bancorp has returned 32.56% as of today's recent price of $18.34.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Announces Closing of SEC Investigation
GlobeNewswire - Tue Aug 13, 8:25AM CDT
Suffolk Bancorp (the "Company"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank"

, today announced that the previously disclosed investigation by the U.S. Securities and Exchange Commission (the "SEC"

has been closed and no action has been taken against the Company. The SEC's New York regional office had formally requested certain loan files, other records and information from the Company in connection with its investigation but had not asserted that any federal securities law violation had occurred.
SUBK: 22.99 (+0.07)

HOWARD C. BLUVER of Suffolk Bancorp (SUBK)-NasdaqGS bought Shares of SUBK
M2 - Fri Aug 09, 7:28AM CDT
Reported by InsiderCow.com at 2013-08-08 13:46:46 ET
SUBK: 22.99 (+0.07)

33.8% Return Seen to Date on SmarTrend Suffolk Bancorp Call (SUBK)
Comtex SmarTrend(R) - Tue Aug 06, 9:20AM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on January 18th, 2013 at $13.84. In approximately 7 months, Suffolk Bancorp has returned 33.79% as of today's recent price of $18.51.
SUBK: 22.99 (+0.07)

Suffolk Bancorp Announces Pre-Tax Gain of $3.8 Million on Sale of Visa Class B Shares
GlobeNewswire - Mon Aug 05, 8:00AM CDT
Suffolk Bancorp (the "Company"

(Nasdaq:SUBK), parent company of Suffolk County National Bank (the "Bank"

, today announced that the Bank sold 50,000 shares of its Visa, Inc. ("Visa"

Class B common stock at a pre-tax gain of approximately $3.8 million. Given the significant rise in the price of Visa common stock over the past twelve months, the Bank thought it prudent to monetize the gain of a portion of the Class B shares it holds in portfolio.
SUBK: 22.99 (+0.07)

Robbins Geller Rudman & Dowd LLP Announces Suffolk Bancorp Securities Settlement
Business Wire - Fri Aug 02, 11:00AM CDT
TO: ALL PERSONS WHO PURCHASED THE COMMON STOCK OF SUFFOLK BANCORP ("SUFFOLK"

DURING THE PERIOD FROM MARCH 12, 2010 THROUGH AUGUST 10, 2011, INCLUSIVE
SUBK: 22.99 (+0.07)

Suffolk Bancorp Has Returned 35.9% Since SmarTrend Recommendation (SUBK)
Comtex SmarTrend(R) - Mon Jul 22, 11:12AM CDT
SmarTrend identified an Uptrend for Suffolk Bancorp (NASDAQ:SUBK) on January 18th, 2013 at $13.84. In approximately 6 months, Suffolk Bancorp has returned 35.89% as of today's recent price of $18.80.
SUBK: 22.99 (+0.07)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

BAIC FOTON Eyes African Market with Strategic Moves

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...